Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Poynard

Showing results (321-330 of 324) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 324 results.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Gut|September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis CS Rüeger, P-Y Bochud, J-F Dufour, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Mechanisms of alcoholic liver disease: cytokinesM G Neuman, D A Brenner, B Rehermann, et al.
Journal of Viral Hepatitis|July 2, 2013
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirinM P Manns, P J Pockros, G Norkrans, et al.
Pageof 33

Showing results (321-330 of 324) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 324 results.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Gut|September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis CS Rüeger, P-Y Bochud, J-F Dufour, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Mechanisms of alcoholic liver disease: cytokinesM G Neuman, D A Brenner, B Rehermann, et al.
Journal of Viral Hepatitis|July 2, 2013
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirinM P Manns, P J Pockros, G Norkrans, et al.
Pageof 33